Use of Compounded Radiopharmaceuticals and Adjunct Drug Preparations Policy Statement

Some nuclear pharmacies compound certain radiopharmaceuticals and adjunct drugs, especially during times of shortages, after discontinuation by the manufacturer not related to safety issues, and for other reasons. A number of issues must be considered by a nuclear medicine facility before procurement of compounded durgs from a nuclear pharmacy. SNMMI developed the document "Use of Compounded Radiopharmaceuticals and Adjunct Drug Preperations" to address many of these considerations.